Log in

Start free trial
Home 5 Lab Industry Advisor 5 Lab Compliance Advisor 5 CLIA-lca 5 FDA Watch: Zepto Life Technology Receives FDA Breakthrough Designation for Blood-Based Mold Test

FDA Watch: Zepto Life Technology Receives FDA Breakthrough Designation for Blood-Based Mold Test

by | Jul 17, 2026 | CLIA-lca, CLIA-nir, Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate

Zepto Life Technology received FDA breakthrough designation for a mold panel
iStock, unomat

Subscribe to view Essential

Start a Free Trial for immediate access to this article

TRY FOR FREE